OBJECTIVES:Acid-reducing agents (ARAs) and proton-pump inhibitors (PPIs) that increase gastric pH can alter the bioavailability of antiviral drugs, particularly relevant in patients with advanced liver disease caused by chronic hepatitis C virus (HCV) infection seeking therapy. Using integrated data from six phase 3 studies, we report the safety and efficacy of the 3-direct-acting antiviral (DAA) regimen containing ombitasvir (OBV, an NS5A inhibitor), ritonavir-boosted paritaprevir (PTV/r, an NS3/4A protease inhibitor), and dasabuvir (DSV, an NS5B polymerase inhibitor) with or without ribavirin (RBV) for HCV genotype 1 patients taking concomitant ARAs and PPIs.METHODS:Treatment-naïve or peginterferon/RBV treatment-experienced patients with or without compensated cirrhosis received OBV/PTV/r and DSV with or without weight-based RBV. Rates of sustained virologic response (SVR), defined as HCV RNA below the lower limit of quantification, 12 weeks post-treatment (SVR12) and safety were evaluated in patients who were receiving concomitant ARAs.RESULTS:Among 2,053 patients enrolled and dosed with study drug, 410 (20�were receiving concomitant ARAs; of these, 308 (15�were taking concomitant PPIs. Rates of SVR12 were 95.9�95�onfidence interval (CI) 93.5–97.4�among patients receiving an ARA, and 96.3�95�I 95.3–97.2�in patients not receiving a concomitant ARA. Similarly, among patients receiving a PPI or not, SVR12 was achieved in 95.1�95�I 92.1–97.0�and 96.4�95�I 95.5–97.2� respectively. Response rates were high regardless of treatment regimen (with or without RBV), and among patients receiving a standard or high dose of PPIs. Regarding safety, adverse events and serious adverse events were more frequently reported in patients taking concomitant ARAs, though baseline population differences may have played a role.CONCLUSIONS:In phase 3 trials of OBV/PTV/r plus DSV and RBV in HCV genotype 1-infected patients, SVR12 rates were high regardless of ARA/PPI use or PPI dose. These data support the co-administration of this regimen with ARAs including PPIs.
genotype            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Genotype              

ARAs                          0.9999980043978115^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Aras_River            

PTV                           0.5792073854827479^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pakistan_Television_Corporation

safety                        0.9997619987065252^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Safety                

interval                      0.9951212776997873^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Time                  

virus                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Virus                 

ARAs                          0.9999980043978115^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Aras_River            

antiviral drugs               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Antiviral_drug        

safety                        0.9997619987065252^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Safety                

DSV                           0.889315698651226^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Verbandsbauart        

gastric                       0.6588794952708901^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stomach               

phase 3                       0.9999998455118776^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Clinical_trial        

ARAs                          0.9999980043978115^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Aras_River            

polymerase                    0.9759226470038185^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/RNA_polymerase        

HCV                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hepatitis_C_virus     

RNA                           0.9935072836804335^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/RNA                   

quantification                0.9193367163017836^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Level_of_measurement  

pH                            0.9999999999968168^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/PH                    

hepatitis                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hepatitis             

DAA                           0.897091679631271^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Dublin_Airport_Authority

ARAs                          0.9999980043978115^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Aras_River            

DSV                           0.889315698651226^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Verbandsbauart        

PTV                           0.5792073854827479^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pakistan_Television_Corporation

adverse events                0.9999999395031427^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

PTV                           0.5792073854827479^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pakistan_Television_Corporation

peginterferon                 0.9696331775812579^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/interferon            

HCV                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hepatitis_C_virus     

NS5B                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/NS5B                  

PPI                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Proton-pump_inhibitor 

NS3                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/NS3_(HCV)             

protease inhibitor            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Protease_inhibitor_(pharmacology)

inhibitor                     0.9999999952460712^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

infection                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Infection             

safety                        0.9997619987065252^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Safety                

drug                          0.983298965943067^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Pharmaceutical_drug   

PPI                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Proton-pump_inhibitor 

bioavailability               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bioavailability       

PPI                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Proton-pump_inhibitor 

liver disease                 0.9998142424473383^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Liver                 

ARAs                          0.9999980043978115^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Aras_River            

HCV                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hepatitis_C_virus     

phase 3                       0.9999998455118776^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Clinical_trial        

cirrhosis                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cirrhosis             

ARA                           0.6639235640963531^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Argentine_Navy        

ribavirin                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ribavirin             

ARA                           0.6639235640963531^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Argentine_Navy        

CI                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Confidence_interval   

proton-pump inhibitors        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Proton-pump_inhibitor 

ARA                           0.6639235640963531^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Argentine_Navy        

efficacy                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Efficacy              

genotype                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Genotype              

HCV                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hepatitis_C_virus     

SVR                           0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Foreign_Intelligence_Service_(Russia)

antiviral                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Antiviral_drug        

NS5A                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/NS5A                  

inhibitor                     0.9999999952460712^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

adverse events                0.9999999395031427^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

DSV                           0.889315698651226^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Verbandsbauart        

